Taiwan FDA registration c9f0ac7bdb28d7eb0ed5691f53e40bab

Vetex Biochemical Products No. 6 Correction Solution

TW: 維特司生化產品6號校正液
Taiwan flagTaiwan·Risk Class 2·ORTHO-CLINICAL DIAGNOSTICS, INC·Registered Aug 18, 2005 – Aug 18, 2025Expired
Registration details
Analysis ID
c9f0ac7bdb28d7eb0ed5691f53e40bab
Customs Code
DHA00601208602
Company information
Manufacturer Country
United States
Authorized Representative
DKSH TAIWAN LTD.
Product details
Intended Use
Vetex 6 Correction Solution is used to correct the quantitative measurement of Vetex biochemical system isomeric per chole lipid and muscle base per isomeric component. The following blank change performance (new applicable models) is: For in vitro diagnostic use only. This product is used to correct the quantitative measurement of bilifibrosterase and myosylase isomerase in the Vitex biochemical system. This product is required for use with the Vitex 350/5,1 FS/4600/XT3400 chemical analyzer and the Vitex 5600/XT7600 biochemical immunoassay analyzer. The following blanks
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Import Information
import
Dates and status
Registration Date
Aug 18, 2005
Expiry Date
Aug 18, 2025
About this record

Access comprehensive regulatory information for Vetex Biochemical Products No. 6 Correction Solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c9f0ac7bdb28d7eb0ed5691f53e40bab and manufactured by ORTHO-CLINICAL DIAGNOSTICS, INC. The authorized representative in Taiwan is DKSH TAIWAN LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices